MedTech Acquisition Co. (NASDAQ:MTAC) Short Interest Update

MedTech Acquisition Co. (NASDAQ:MTACGet Rating) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totalling 13,900 shares, a decline of 38.2% from the April 15th total of 22,500 shares. Based on an average daily trading volume, of 256,700 shares, the days-to-cover ratio is presently 0.1 days.

Institutional investors have recently modified their holdings of the company. Morgan Stanley raised its stake in shares of MedTech Acquisition by 4,104.0% in the 3rd quarter. Morgan Stanley now owns 4,204 shares of the company’s stock valued at $42,000 after purchasing an additional 4,104 shares in the last quarter. CWM LLC acquired a new stake in shares of MedTech Acquisition in the 4th quarter valued at about $49,000. Ancora Advisors LLC acquired a new stake in shares of MedTech Acquisition in the 3rd quarter valued at about $51,000. Penserra Capital Management LLC acquired a new stake in shares of MedTech Acquisition in the 4th quarter valued at about $54,000. Finally, State Street Corp acquired a new stake in shares of MedTech Acquisition in the 4th quarter valued at about $113,000. Institutional investors and hedge funds own 64.61% of the company’s stock.

Shares of MTAC stock opened at $9.79 on Friday. The company’s fifty day moving average price is $9.82 and its two-hundred day moving average price is $9.89. MedTech Acquisition has a 12 month low of $8.99 and a 12 month high of $10.30.

MedTech Acquisition Company Profile (Get Rating)

MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Greenwich, Connecticut.

See Also

Receive News & Ratings for MedTech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedTech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.